COR vs WST: fair value comparison
Cencora, Inc. and West Pharmaceutical Services, Inc. · Updated 2026-10-19
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, COR currently sits closer to the top of our ranking by discount to fair value. WST carries the stronger quality grade.
| COR | WST | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $323.85 | $366.00 |
| 12-month range | $252.74–$374.75 | $230.95–$384.02 |
| Rank by discount to fair value | #58 of 108 Healthcare | #60 of 108 Healthcare |
| Quality grade | F | A |
| Leverage | High | Low |
| Margin trend | Stable | Expanding |
| Revenue growth | Modest | Modest |
| RSI zone | Overbought | Neutral |
| DCF cross-check | Overvalued | — |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: COR fair value analysis · WST fair value analysis